NCT03549273 2024-02-07Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial LesionsCatalysis SLPhase 2 Unknown62 enrolled
NCT03562897 2022-07-06Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial CancerCatalysis SLPhase 2 Completed40 enrolled
NCT00326885 2018-10-17Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant AscitesNeovii BiotechPhase 2 Completed32 enrolled 12 charts
NCT01431391 2017-05-30Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate CancerDendreonPhase 2 Completed68 enrolled 11 charts